Research & Development Consolidation Project
Research & Development Consolidation Project
The Research and Development Consolidation project for Janssen Pharmaceuticals, now Johnson & Johnson Innovative Medicine, brings together research facilities, an innovation center, offices, employee amenities and support spaces into one central location. This facility advances their mission to drive innovation through collaboration to develop much needed medicines faster and more efficiently.
Project Details
Located at Sierra Point in Brisbane, the 154,000 sq.-ft Research and Development project accommodates 400 researchers and staff and consists of two buildings, each with four floors and a connecting bridge.
The Research and Development Consolidation project brings together research facilities, an innovation center, offices, employee amenities, multi-purpose gathering spaces, and support spaces into one central location. This facility will conduct research around gene and RNA therapies, experimental treatments for infectious and retinal diseases, and focus on digital health and data science.
The design of the fit-out encourages interaction and thought sharing between researchers, who are traditionally siloed, in a creative and informal environment where workplace and community spaces are directly adjacent to the research laboratories.
